Literature DB >> 4061566

Acute colitis produced by chemotactic peptides in rats and mice.

J F Chester, J S Ross, R A Malt, S A Weitzman.   

Abstract

Colonic inflammation was produced in rats and mice by peptides chemotactic for polymorphonuclear leukocytes. Instillation of formylmethionyl-leucyl-phenylalanine (FMLP) and formylnorleucyl-leucyl-phenylalanine (FNLP) into isolated segments of rat colon caused marked mucosal edema and polymorphonuclear leukocyte infiltration within 2 hours. Higher concentrations of FNLP caused ulceration and necrosis as well. Formylmethionine (FMet), a compound with less chemotactic activity, caused much less inflammation. In mice, rectal instillation of FNLP caused dose-dependent acute mucosal inflammation which persisted for longer than 12 hours. Twice-weekly rectal instillation of FNLP provided a model of colitis based on neutrophil chemotaxis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4061566      PMCID: PMC1888052     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Spasmogenic activity of chemotactic N-formylated oligopeptides: identity of structure--function relationships for chemotactic and spasmogenic activities.

Authors:  W A Marasco; J C Fantone; P A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

2.  Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions.

Authors:  J C Fantone; P A Ward
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

3.  The role of oxygen free radicals in human disease processes.

Authors:  G B Bulkley
Journal:  Surgery       Date:  1983-09       Impact factor: 3.982

4.  Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.

Authors:  W A Marasco; S H Phan; H Krutzsch; H J Showell; D E Feltner; R Nairn; E L Becker; P A Ward
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

5.  The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.

Authors:  H Z Movat; C Rettl; C E Burrowes; M G Johnston
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

6.  Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa.

Authors:  N K Boughton-Smith; C J Hawkey; B J Whittle
Journal:  Gut       Date:  1983-12       Impact factor: 23.059

7.  Chemotaxis and random migration of polymorphonuclear leukocytes in ulcerative colitis examined by the agarose method.

Authors:  A Hermanowicz; Z Nawarska
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

8.  Proteases and oxidants in experimental pulmonary inflammatory injury.

Authors:  I U Schraufstätter; S D Revak; C G Cochrane
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  The superoxide free radical: its biochemistry and pathophysiology.

Authors:  J M McCord
Journal:  Surgery       Date:  1983-09       Impact factor: 3.982

Review 10.  Role of oxygen-derived free radicals in digestive tract diseases.

Authors:  D A Parks; G B Bulkley; D N Granger
Journal:  Surgery       Date:  1983-09       Impact factor: 3.982

View more
  22 in total

1.  Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response.

Authors:  Giovanna Leoni; Jeannie Gripentrog; Connie Lord; Marcia Riesselman; Ronen Sumagin; Charles A Parkos; Asma Nusrat; Algirdas J Jesaitis
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

Review 2.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

3.  Effect of bacterial chemotactic peptides on intestinal inflammation in animal models of acute and chronic "relapsed" colitis.

Authors:  Gerardo A Hernández; Melanie R Valentín; Caroline B Appleyard
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 4.  Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

Authors:  I A Schepetkin; A I Khlebnikov; M P Giovannoni; L N Kirpotina; A Cilibrizzi; M T Quinn
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP).

Authors:  P Anton; J O'Connell; D O'Connell; L Whitaker; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

6.  Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

Authors:  Keqiang Chen; Mingyong Liu; Ying Liu; Teizo Yoshimura; Wei Shen; Yingying Le; Scott Durum; Wanghua Gong; Chunyan Wang; Ji-Liang Gao; Philip M Murphy; Ji Ming Wang
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

7.  Pathogenesis of Campylobacter spp. in athymic and euthymic germfree mice.

Authors:  J W Yrios; E Balish
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

8.  Neutrophil activation by Helicobacter pylori.

Authors:  C Mooney; J Keenan; D Munster; I Wilson; R Allardyce; P Bagshaw; B Chapman; V Chadwick
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

9.  Production of chemoattractant by Helicobacter pylori.

Authors:  A Reymunde; J Deren; I Nachamkin; D Oppenheim; G Weinbaum
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

Review 10.  Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease.

Authors:  C C Nast; L E LeDuc
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.